Abeona therapeutics appoints gene therapy quality leader jon voss as vice president, head of quality

New york and cleveland, oct. 12, 2021 (globe newswire) -- abeona therapeutics inc. (nasdaq: abeo), a fully-integrated leader in gene and cell therapy, today announced the appointment of jon voss as vice president, head of quality. mr. voss, who has been advising the company as a consultant, will now serve in a leadership role to further strengthen abeona's quality system and oversee all quality functions.
ABEO Ratings Summary
ABEO Quant Ranking